ExLibris header image
SFX Logo
Title: Derivation, Characterization, and Neural Differentiation of Integration-Free Induced Pluripotent Stem Cell Lines from Parkinson’s Disease Patients Carrying SNCA, LRRK2, PARK2, and GBA Mutations
Source:

Plos One [1932-6203] Momcilovic, Olga yr:2016


Collapse list of basic services Basic
Full text
Full text available via PubMed Central
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Daher, João P. L. B. "Leucine-rich Repeat Kinase 2 (LRRK2) Pharmacological Inhibition Abates α-Synuclein Gene-induced Neurodegeneration." Journal of biological chemistry 290.32 (2015): 19433-19444. Link to Full Text for this item Link to SFX for this item
2. Bandres Ciga, S. "Analysis of the genetic variability in Parkinson's disease from Southern Spain." Neurobiology of Aging 37 (2016): 2100-21000000. Link to SFX for this item
3. Rockenstein, E. "Glucocerebrosidase Modulates Cognitive and Motor Activities in Murine Models of Parkinson's Disease." Human molecular genetics 25.13 (2016): 2645-2660. Link to SFX for this item
4. Fox, Susan H. "Improved viability of stem cell transplants in animal models of Parkinson's disease." Movement disorders 27.7 (2012): 814-814. Link to Full Text for this item Link to SFX for this item
5. "Imaging Leucine-Rich Repeat Kinase 2 In Vivo with 18 F-Labeled Positron Emission Tomography Ligand." Journal of medicinal chemistry 66.3: 1712-1724. Link to SFX for this item
6. P, S. "Isolation of heat-stable glucocerebrosidase activators from the spleens of three variants of Gaucher's disease." Archives of biochemistry and biophysics 183.1 (1977): 290-297. Link to Full Text for this item Link to SFX for this item
7. Maor, G. "The contribution of mutant GBA to the development of parkinson disease in Drosophila." Human molecular genetics 25.13 (2016): 2712-2727. Link to SFX for this item
8. Escott Price, V. "Common polygenic variation enhances risk prediction for Alzheimer's disease." Brain 138.Pt 12 (2015): 3673-84. Link to SFX for this item
9. Fell, Matthew J. "MLi-2, a Potent, Selective, and Centrally Active Compound for Exploring the Therapeutic Potential and Safety of LRRK2 Kinase Inhibition." The journal of pharmacology and experimental therapeutics 355.3 (2015): 397-409. Link to SFX for this item
10. Bourdenx, M. "Allograft of stem cell-derived dopaminergic neurons for Parkinson's disease." Movement disorders 28.6 (2013): 736-736. Link to Full Text for this item Link to SFX for this item
11. Brunstein, Claudio G. "Reduced-intensity conditioning transplantation in acute leukemia: the effect of source of unrelated donor stem cells on outcomes." Blood 119.23 (2012): 5591-5598. Link to SFX for this item
12. Jung, Yong W. "Human induced pluripotent stem cells and neurodegenerative disease: prospects for novel therapies." Current opinion in neurology 25.2 (2012): 125-130. Link to SFX for this item
13. Storch, Alexander i. "Stem cell-based therapies in Parkinson’s disease: future hope or current treatment option?" Journal of neurology 258.2 (2011): 346-353. Link to SFX for this item
14. Gerlach, M. "Current state of stem cell research for the treatment of Parkinson's disease." Journal of neurology 249.3 (2002): 1-5. Link to Full Text for this item Link to SFX for this item
15. Cooper, O. "Using stem cells and iPS cells to discover new treatments for Parkinson's disease." Parkinsonism & related disorders 18 Suppl 1.s (2012): 14-6. Link to SFX for this item
16. Politis, M. "Clinical application of stem cell therapy in Parkinson's disease." BMC medicine 10.1 (2012): 1-1. Link to Full Text for this item Link to SFX for this item
17. Hassin Baer, S. "Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations." Parkinsonism & related disorders 62 (2019): 179-184. Link to SFX for this item
18. Tozzi, A. "Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease." Neurobiology of disease. 118: 1-8. Link to SFX for this item
19. "Differentiated versus undifferentiated mesenchymal stem cell therapy in paraquat model of Parkinson's disease." Movement disorders 31.s2. Link to SFX for this item
20. Alcalay, Roy N. "SCARB2 variants and glucocerebrosidase activity in Parkinson's disease." NPJ Parkinson's Disease 2.1 (2016): 16004-. Link to Full Text for this item Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.